184 related articles for article (PubMed ID: 15165404)
21. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
[TBL] [Abstract][Full Text] [Related]
22. Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: a pilot study.
Riccio A; Postiglione L; Sabatini P; Linvelli M; Soriente I; Sangiolo MG; Amato P; Tarantino G
Int J Immunopathol Pharmacol; 2012; 25(1):281-5. PubMed ID: 22507342
[TBL] [Abstract][Full Text] [Related]
23. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
24. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
25. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
[TBL] [Abstract][Full Text] [Related]
26. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
[TBL] [Abstract][Full Text] [Related]
27. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
Shang J; Xu Y; Zhang H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):87-8. PubMed ID: 10861111
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H; Robak E
Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
[TBL] [Abstract][Full Text] [Related]
29. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.
Won HS; Kim YA; Lee JS; Jeon EK; An HJ; Sun DS; Ko YH; Kim JS
Cancer Invest; 2013 Oct; 31(8):516-21. PubMed ID: 23902164
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia.
Hatzimichael EC; Christou L; Bai M; Kolios G; Kefala L; Bourantas KL
Eur J Haematol; 2001 Jan; 66(1):1-6. PubMed ID: 11168500
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
Pulsatelli L; Boiardi L; Assirelli E; Pazzola G; Muratore F; Addimanda O; Dolzani P; Versari A; Casali M; Magnani L; Pignotti E; Pipitone N; Croci S; Meliconi R; Salvarani C
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
[TBL] [Abstract][Full Text] [Related]
34. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome.
Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA
Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646
[TBL] [Abstract][Full Text] [Related]
35. The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy.
Kovacs E
Biomed Pharmacother; 2005 Oct; 59(9):498-500. PubMed ID: 16202558
[TBL] [Abstract][Full Text] [Related]
36. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis.
Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV
Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
[TBL] [Abstract][Full Text] [Related]
38. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis.
Petrinović-Doresić J; Mazuran R; Henc-Petrinović L; Kuzmanović B; Jovicić A
Ocul Immunol Inflamm; 1999 Jun; 7(2):75-84. PubMed ID: 10420202
[TBL] [Abstract][Full Text] [Related]
40. Relationship among serum levels of IL-6, sIL-6R, s gp130 and CD126 on T-cell in HIV-1 infected and uninfected men participating in the Los Angeles Multi-Center AIDS Cohort Study.
Aziz N; Shih R; Alexopoulos N; Jamieson BD; Mimiaga MJ; Martinez-Maza O; Detels R
PLoS One; 2023; 18(10):e0290702. PubMed ID: 37812611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
